Canada markets closed

Abeona Therapeutics Inc. (ABEO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.4100+0.8900 (+25.28%)
At close: 04:00PM EDT
4.5499 +0.14 (+3.17%)
After hours: 07:37PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close3.5200
Open3.5000
Bid4.4500 x 1400
Ask4.5500 x 1800
Day's Range3.5000 - 4.8694
52 Week Range0.2700 - 26.5000
Volume4,501,156
Avg. Volume217,182
Market Cap646.585M
Beta (5Y Monthly)1.24
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Abeona Therapeutics Announces Completion of Patient Follow-up in Pivotal Phase 3 VIITAL™ Study of EB-101 in Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)

    Topline VIITAL™ study results expected within the next monthNEW YORK and CLEVELAND, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that the last patient has completed their 6-month follow-up visit in Abeona’s pivotal Phase 3 VIITAL™ study of its investigational autologous, engineered cell therapy, EB-101, in patients with recessive dystrophic epidermolysis bullosa (RDEB). “Completion of the last patient’s 6-month follow-up visit marks a key milestone th

  • GlobeNewswire

    Abeona Therapeutics to Participate in the Jefferies Cell and Genetic Medicine Summit

    NEW YORK and CLEVELAND, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Vish Seshadri, Chief Executive Officer of Abeona, will participate in a fireside chat at the Jefferies Cell and Genetic Medicine Summit on Friday, September 30, 2022 at 8:30 a.m. ET. The Company will also participate in one-on-one investor meetings at the conference. A live webcast of the fireside chat will be available on the Investors section of the Abeona website under "Even

  • GlobeNewswire

    Abeona Therapeutics to Participate in the Cantor Fitzgerald Cell and Genetic Medicines Conference

    NEW YORK and CLEVELAND, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Vish Seshadri, Chief Executive Officer of Abeona, will participate in a panel discussion at the Cantor Fitzgerald Cell and Genetic Medicines Conference on Thursday, September 15, 2022. The panel discussion, entitled, “Late Stage and Commercial Gene & Cell Therapy Warriors: How They Got to/Crossed the Finish Line,” is scheduled to begin at 2:30 p.m. ET. The Company will also par